43(B)log

JANUARY 5, 2024

The parties settled in 2015; defendants agreed to cease their use of those marks and to avoid the words “Florida” and “Virtual” together in a mark. 2, 2024) Some interesting comments on when individual instances of “confusion” don’t count, as well as their relevance to evaluating out-of-court social media etc.

Branding 59

Branding Brands Branding Marketing 59

The IP Law Blog

MARCH 2, 2021

When settlement discussions proved fruitless, Romag sued. But the majority and concurring opinions’ directive that mental state is a “highly important consideration” should mean that losing the willfulness requirement will not make it easier for spurious filings aimed at extracting a quick settlement. 31 Such improvements may give U.S.

Intellectual Property 52

Intellectual Property Contracts Trademark Trademark Law 52

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

For the first time since FDA licensed the first biosimilar, Sandoz’s Zarxio ® (filgrastim-sndz), in 2015, the United States saw a decrease in annual biosimilar approvals in 2020. Figure 1, below, provides a snapshot of FDA approval and biosimilar product launch trends from 2015 through 2020. 2015; resubmitted Feb. Conclusion.

Litigation 52

Litigation Settlement Marketing Marketing 52

The IPKat

SEPTEMBER 12, 2021

This followed the end of the parties peace agreement provided for by a settlement agreement following the last bout of litigation. This UK action is one of a number of actions that have recently been started by the parties globally.

Litigation 98

Litigation Patent Marketing Marketing 98

Patently-O

APRIL 12, 2024

It simplifies the process of obtaining and maintaining industrial design protection internationally by enabling applicants to secure protection in any of the Hague System’s contracting parties through a single application, in one language, and with one set of fees.

Designs 40

Designs Design Law Registration 40

Patently-O

FEBRUARY 22, 2023

It generally amounts to more than 50% of the total settlement recovery, acknowledging, at least by basic math, that they are the primary beneficiary of the litigation.). self-reporting that “IP EDGE has returned over 3x the money it has invested in patents in the 2015-2021 time period with no down years”). [16] 2d 217, 221 (Ohio 2003).

Litigation 126

Litigation Reporting Settlement Government 126

The IPKat

AUGUST 2, 2023

The Judge noticed that the worldwide average selling prices (‘ASP’) by region presented by Meyer demonstrated the trend over 2015 – 2021 that China’s ASPs grew closer to the Developed Market ASPs.

Marketing 52

Marketing Marketing Licensing Patent 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

Figure 1 below provides an overview of biosimilar approvals by FDA and product launches in the United States from 2015 to 2021. No earlier than 2023 per settlement. No earlier than 2023 per settlement. No earlier than 2023 per settlement. . 2015; resubmitted Feb. No earlier than 2023 per settlement.

Litigation 52

Litigation Settlement Patent Marketing 52

LexBlog IP

JUNE 7, 2023

27] The purpose of the report is therefore twofold: to encourage settlement and to provide transparency on the process and recommended FRAND in cases of disagreement. [28] See Cleary IP and Technology Insights, Contracts involving European Patents: Five Steps to Take Now in the Wake of the New EU Unitary Patent System for further details. [4]

Licensing 52

Licensing Patent Confidentiality Registration 52